Anzeige
Mehr »
Mittwoch, 07.01.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M4X5 | ISIN: CNE100000387 | Ticker-Symbol: GU5
Frankfurt
07.01.26 | 08:02
1,980 Euro
-0,50 % -0,010
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD Chart 1 Jahr
5-Tage-Chart
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,9902,06009:04

Aktuelle News zur GUANGZHOU BAIYUNSHAN PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.12.25BAIYUNSHAN PH (00874): POLL RESULTS OF THE THIRD EXTRAORDINARY GENERAL MEETING IN 2025 HELD ON 30 DECEMBER 20251
29.12.25Guangzhou Pharma Targets USD1.4 Billion R&D Push, USD2.8 Billion in Deals Under 15th Five-Year Plan1
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL Aktie jetzt für 0€ handeln
29.12.25BAIYUNSHAN PH (00874): ANNOUNCEMENT ON THE PROGRESS OF CONNECTED TRANSACTION - PARTICIPATION IN THE ESTABLISHMENT OF GP GUANGKAI FUND AND GP LIWAN FUND-
22.12.25BAIYUNSHAN PH (00874): NEW CONTINUING CONNECTED TRANSACTIONS AGREEMENT1
22.12.25BAIYUNSHAN PH (00874): CONNECTED TRANSACTION - PARTICIPATION IN THE ESTABLISHMENT OF GP GUANGKAI FUND AND GP LIWAN FUND1
17.12.25BAIYUNSHAN PH (00874): DISCLOSABLE TRANSACTION - ACQUISITION OF 100% EQUITY INTEREST IN THE TARGET COMPANY1
05.12.25BAIYUNSHAN PH (00874): PROXY FORM FOR THE THIRD EXTRAORDINARY GENERAL MEETING IN 2025-
05.12.25BAIYUNSHAN PH (00874): NOTICE OF THE THIRD EXTRAORDINARY GENERAL MEETING IN 2025-
05.12.25BAIYUNSHAN PH (00874): (1) PROPOSED ASSET-BACKED SECURITIZATION OF ACCOUNTS RECEIVABLE BY GP CORP.; (2) PROPOSED SETTLEMENT OF PROJECTS INVESTED BY PROCEEDS ...-
01.12.25BAIYUNSHAN PH (00874): PROPOSED DISPOSALS OF ACCOUNTS RECEIVABLE1
28.11.25BAIYUNSHAN PH (00874): DISCLOSABLE TRANSACTION: DISPOSALS OF ACCOUNTS RECEIVABLE4
27.11.25BAIYUNSHAN PH (00874): VOLUNTARY ANNOUNCEMENT - ENTERING INTO A LAND RESERVE COMPENSATION AGREEMENT-
28.10.25BAIYUNSHAN PH (00874): GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED BOARD DIVERSITY POLICY1
28.10.25BAIYUNSHAN PH (00874): GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED RULES OF PROCEDURES FOR THE NOMINATION AND REMUNERATION COMMITTEE ...-
28.10.25BAIYUNSHAN PH (00874): GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED RULES OF PROCEDURES FOR THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS-
28.10.25BAIYUNSHAN PH (00874): 2025 THIRD QUARTERLY REPORT3
23.10.25BAIYUNSHAN PH (00874): SUPPLEMENTARY ANNOUNCEMENT - DISCLOSABLE TRANSACTION: ACQUISITION OF 11.04% EQUITY INTEREST IN THE TARGET COMPANY-
14.10.25BAIYUNSHAN PH (00874): DATE OF BOARD MEETING1
26.09.25BAIYUNSHAN PH (00874): THE RULES OF PROCEEDINGS FOR THE BOARD OF DIRECTORS3
26.09.25BAIYUNSHAN PH (00874): RULES OF PROCEDURES FOR SHAREHOLDERS' MEETINGS1
Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1